Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $57.00
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price target raised by Guggenheim from $55.00 to $57.00 in a research note released on Thursday, MarketBeat reports. They currently have a buy rating on the stock. A number of other research analysts also recently issued reports on AMLX. Robert W. Baird boosted their price objective on […]
30 Aug 05:24 · The Markets Daily